A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies
暂无分享,去创建一个
Harumasa Takano | Masanori Ichise | Takashi Yokoi | Yuichi Kimura | Hiroshi Ito | Chie Seki | Mika Naganawa | Hidehiko Takahashi | Tetsuya Suhara | Yoko Ikoma | Miho Shidahara | Hidehiko Takahashi | Y. Kimura | T. Suhara | M. Ichise | Hiroshi Ito | H. Takano | Y. Ikoma | C. Seki | M. Shidahara | M. Naganawa | T. Yokoi
[1] Marie-Claude Asselin,et al. Quantification of PET Studies with the Very High-Affinity Dopamine D2/D3 Receptor Ligand [11C]FLB 457: Re-Evaluation of the Validity of using a Cerebellar Reference Region , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] T Suhara,et al. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[4] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] C. Halldin,et al. Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] Iwao Kanno,et al. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457 , 2008, NeuroImage.
[8] Christer Halldin,et al. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. , 1999, International Journal of Neuropsychopharmacology.
[9] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] G Brix,et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] Christer Halldin,et al. Radioligand Disposition and Metabolism — Key Information in Early Drug Development , 1995 .
[12] Hiroshi Fukuda,et al. A simple method for the quantification of benzodiazepine receptors using iodine-123 iomazenil and single-photon emission tomography , 1996, European Journal of Nuclear Medicine.
[13] D. Comar,et al. PET for drug development and evaluation , 1995 .
[14] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] D. Newport,et al. A Single Scatter Simulation Technique for Scatter Correction in 3D PET , 1996 .
[16] N. Lassen,et al. Neuroreceptor Quantitation in vivo by the Steady-State Principle Using Constant Infusion or Bolus Injection of Radioactive Tracers , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] I Kanno,et al. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] Kunihiro Chihara,et al. Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis , 2005, NeuroImage.
[19] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[20] D L Alexoff,et al. A Strategy for Removing the Bias in the Graphical Analysis Method , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] P. Grangeat,et al. Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine , 1996, Computational Imaging and Vision.
[22] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] Christer Halldin,et al. Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC , 1994 .
[24] M E Phelps,et al. Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] A. Gjedde,et al. Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.